Health Canada has cleared Novo Nordisks’s weight loss drug Wegovy to reduce the risk of non-fatal heart attacks.

Wegovy and other GLP-1 medications have become extremely popular over the past few years. Novo Nordisk (which makes both ...

With several of these drugs going off patent in the next few years, OneSource is poised to see big growth in the generic ...

Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as ...

Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk.

Packaged-food giant Conagra Foods is hoping to appeal to people taking weight-loss drugs with frozen entrees like chicken fettuccini alfredo or meatball marinara. Starting in January, 26 items in ...

Recently, weight loss drugs like Ozempic and Wegovy have gained widespread attention, transforming the landscape of obesity management and weight loss treatments. Initially developed for the treatment ...

The trial, known as SURMOUNT-5, found that participants using Zepbound lost an average of 20.2% of their body weight, while those on Wegovy lost 13.7%. This marks a 47% difference in weight loss ...

Medication fills for Zepbound have increased by more than 300% since the start of the year. The average out-of-pocket cost for patients was $230 per fill — the highest of any medication included in ...

Ms. Gantt is now missing her colon and has an ileostomy bag attached to her abdomen. Now, she is suing Novo Nordisk, claiming that the drug's labels do not warn of all serious side effects, including ...

Barriers to accessing GLP-1 medications are beginning to break down as drug manufacturers, insurers, and lawmakers look to expand availability, lower costs, and address continued high demand.